Infection with hepatitis E virus in kidney transplant recipients in southeastern France

Journal of Medical Virology

Volumn 85, Issue 3, 2013, Pages 462-471

  Moal, Valérie ^a,b   Legris, Tristan ^a,c   Burtey, Stéphane ^a,c   Morange, Sophie ^a   Purgus, Raj ^a   Dussol, Bertrand ^a,c   Garcia, Stéphane ^c,d   Motte, Anne ^e   Gérolami, René ^a,c   Berland, Yvon ^a,c   Colson, Philippe ^b,e  

^a HÔPITAL DE LA CONCEPTION   (France)

^b AIX MARSEILLE UNIVERSITÉ   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d HÔPITAL NORD   (France)

^e TIMONE HOSPITAL   (France)

Author keywords

Autochthonous infection; Chronic hepatitis E; France; Hepatitis E virus; Kidney transplantation; Transplant recipient

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ACUTE GRAFT REJECTION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; FRANCE; HEPATITIS E; HUMAN; INFECTION COMPLICATION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVER CIRRHOSIS; MALE; RETROSPECTIVE STUDY; VIRAL CLEARANCE;

ADULT; AGED; CHRONIC DISEASE; COHORT STUDIES; FEMALE; FRANCE; GENOTYPE; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; TRANSPLANTATION;

EID: 84873203695     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23469     Document Type: Article

References (40)

1. Alric L, Bonnet D, Laurent G, Kamar N, Izopet J. 2010. Chronic hepatitis E virus infection: Successful virologic response to pegylated interferon-alpha therapy. Ann Intern Med 153:135-136.
2. Balayan MS, Andjaparidze AG, Savinskaya SS, Ketiladze ES, Braginsky DM, Savinov AP, Poleschuk VF. 1983. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology 20:23-31.
3. Bouquet J, Tesse S, Lunazzi A, Eloit M, Rose N, Nicand E, Pavio N. 2011. Close similarity between sequences of hepatitis E virus recovered from humans and swine, France, 2008-2009. Emerg Infect Dis 17:2018-2025.
4. Chaillon A, Sirinelli A, De Muret A, Nicand E, d'Alteroche L, Goudeau A. 2011. Sustained virologic response with ribavirin in chronic hepatitis E virus infection in heart transplantation. J Heart Lung Transplant 30:841-843.
5. Colson P, Borentain P, Queyriaux B, Kaba M, Moal V, Gallian P, Heyries L, Raoult D, Gerolami R. 2010. Pig liver sausage as a source of hepatitis E virus transmission to humans. J Infect Dis 202:825-834.
6. Colson P, Dhiver C, Poizot-Martin I, Tamalet C, Gerolami R. 2011. Acute and chronic hepatitis E in patients infected with human immunodeficiency virus. J Viral Hepat 18:227-228.
7. Covic A, Abramowicz D, Bruchfeld A, Leroux-Roels G, Samuel D, van Biesen W, Zoccali C, Zoulim F, Vanholder R. 2009. Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) hepatitis C guidelines: A European Renal Best Practice (ERBP) position statement. Nephrol Dial Transplant 24:719-727.
8. Dalton HR, Bendall R, Ijaz S, Banks M. 2008. Hepatitis E: An emerging infection in developed countries. Lancet Infect Dis 8:698-709.
9. Dalton HR, Bendall RP, Keane FE, Tedder RS, Ijaz S. 2009. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med 361:1025-1027.
10. Gerolami R, Moal V, Colson P. 2008. Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. N Engl J Med 358:859-860.
11. Gerolami R, Moal V, Picard C, Colson P. 2009. Hepatitis E virus as an emerging cause of chronic liver disease in organ transplant recipients. J Hepatol 50:622-624.
12. Haagsma EB, van den Berg AP, Porte RJ, Benne CA, Vennema H, Reimerink JH, Koopmans MP. 2008. Chronic hepatitis E virus infection in liver transplant recipients. Liver Transpl 14:547-553.
13. Haagsma EB, Niesters HG, van den Berg AP, Riezebos-Brilman A, Porte RJ, Vennema H, Reimerink JH, Koopmans MP. 2009. Prevalence of hepatitis E virus infection in liver transplant recipients. Liver Transpl 15:1225-1228.
14. Haagsma EB, Riezebos-Brilman A, van den Berg AP, Porte RJ, Niesters HG. 2010. Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha-2b. Liver Transpl 16:474-477.
15. Halac U, Beland K, Lapierre P, Patey N, Ward P, Brassard J, Houde A, Alvarez F. 2012. Chronic hepatitis E infection in children with liver transplantation. Gut 61:597-603.
16. Kaba M, Davoust B, Marie JL, Barthet M, Henry M, Tamalet C, Raoult D, Colson P. 2009. Frequent transmission of hepatitis E virus among piglets in farms in Southern France. J Med Virol 81:1750-1759.
17. Kamar N, Selves J, Mansuy JM, Ouezzani L, Peron JM, Guitard J, Cointault O, Esposito L, Abravanel F, Danjoux M, Durand D, Vinel JP, Izopet J, Rostaing L. 2008a. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 358:811-817.
18. Kamar N, Mansuy JM, Cointault O, Selves J, Abravanel F, Danjoux M, Otal P, Esposito L, Durand D, Izopet J, Rostaing L. 2008b. Hepatitis E virus-related cirrhosis in kidney- and kidney-pancreas-transplant recipients. Am J Transplant 8:1744-1748.
19. Kamar N, Rostaing L, Abravanel F, Garrouste C, Esposito L, Cardeau-Desangles I, Mansuy JM, Selves J, Peron JM, Otal P, Muscari F, Izopet J. 2010a. Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation. Clin Infect Dis 50:e30-e33.
20. Kamar N, Abravanel F, Selves J, Garrouste C, Esposito L, Lavayssiere L, Cointault O, Ribes D, Cardeau I, Nogier MB, Mansuy JM, Muscari F, Peron JM, Izopet J, Rostaing L. 2010b. Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation. Transplantation 89:353-360.
21. Kamar N, Izopet J, Cintas P, Garrouste C, Uro-Coste E, Cointault O, Rostaing L. 2010c. Hepatitis E virus-induced neurological symptoms in a kidney-transplant patient with chronic hepatitis. Am J Transplant 10:1321-1324.
22. Kamar N, Rostaing L, Abravanel F, Garrouste C, Lhomme S, Esposito L, Basse G, Cointault O, Ribes D, Nogier MB, Alric L, Peron JM, Izopet J. 2010d. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection. Gastroenterology 139:1612-1618.
23. Kamar N, Bendall RP, Peron JM, Cintas P, Prudhomme L, Mansuy JM, Rostaing L, Keane F, Ijaz S, Izopet J, Dalton HR. 2011a. Hepatitis E virus and neurologic disorders. Emerg Infect Dis 17:173-179.
24. Kamar N, Garrouste C, Haagsma EB, Garrigue V, Pischke S, Chauvet C, Dumortier J, Cannesson A, Cassuto-Viguier E, Thervet E, Conti F, Lebray P, Dalton HR, Santella R, Kanaan N, Essig M, Mousson C, Radenne S, Roque-Afonso AM, Izopet J, Rostaing L. 2011b. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 140:1481-1489.
25. Kamar N, Bendall R, Legrand-Abravanel F, Xia NS, Ijaz S, Izopet J, Dalton HR. 2012a. Hepatitis E. Lancet 379:2477-2488.
26. Kamar N, Weclawiak H, Guilbeau-Frugier C, Legrand-Abravanel F, Cointault O, Ribes D, Esposito L, Cardeau-Desangles I, Guitard J, Sallusto F, Muscari F, Peron JM, Alric L, Izopet J, Rostaing L. 2012b. Hepatitis E virus and the kidney in solid-organ transplant patients. Transplantation 93:617-623.
27. Legrand-Abravanel F, Mansuy JM, Dubois M, Kamar N, Peron JM, Rostaing L, Izopet J. 2009. Hepatitis E virus genotype 3 diversity, France. Emerg Infect Dis 15:110-114.
28. Legrand-Abravanel F, Kamar N, Sandres-Saune K, Garrouste C, Dubois M, Mansuy JM, Muscari F, Sallusto F, Rostaing L, Izopet J. 2010. Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France. J Infect Dis 202:835-844.
29. Legrand-Abravanel F, Kamar N, Sandres-Saune K, Lhomme S, Mansuy JM, Muscari F, Sallusto F, Rostaing L, Izopet J. 2011. Hepatitis E virus infection without reactivation in solid-organ transplant recipients, France. Emerg Infect Dis 17:30-37.
30. Lu L, Li C, Hagedorn CH. 2006. Phylogenetic analysis of global hepatitis E virus sequences: Genetic diversity, subtypes and zoonosis. Rev Med Virol 16:5-36.
31. Mallet V, Nicand E, Sultanik P, Chakvetadze C, Tesse S, Thervet E, Mouthon L, Sogni P, Pol S. 2010. Brief communication: Case reports of ribavirin treatment for chronic hepatitis E. Ann Intern Med 153:85-89.
32. Mansuy JM, Bendall R, Legrand-Abravanel F, Saune K, Miedouge M, Ellis V, Rech H, Destruel F, Kamar N, Dalton HR, Izopet J. 2011. Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis 17:2309-2312.
33. Moal V, Gerolami R, Colson P. 2012. First human case of co-infection with two different subtypes of hepatitis E virus. Intervirology 55:484-487.
34. Ollier L, Tieulie N, Sanderson F, Heudier P, Giordanengo V, Fuzibet JG, Nicand E. 2009. Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab. Ann Intern Med 150:430-431.
35. Pas SD, de Man RA, Mulders C, Balk AH, van Hal PT, Weimar W, Koopmans MP, Osterhaus AD, van der Eijk AA. 2012. Hepatitis E virus infection among solid organ transplant recipients, the Netherlands. Emerg Infect Dis 18:869-872.
36. Pischke S, Suneetha PV, Baechlein C, Barg-Hock H, Heim A, Kamar N, Schlue J, Strassburg CP, Lehner F, Raupach R, Bremer B, Magerstedt P, Cornberg M, Seehusen F, Baumgaertner W, Klempnauer J, Izopet J, Manns MP, Grummer B, Wedemeyer H. 2010. Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients. Liver Transpl 16:74-82.
37. Purcell RH, Emerson SU. 2008. Hepatitis E: An emerging awareness of an old disease. J Hepatol 48:494-503.
38. Schlosser B, Stein A, Neuhaus R, Pahl S, Ramez B, Kruger DH, Berg T, Hofmann J. 2012. Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient. J Hepatol 56:500-502.
39. Verhoeven Y, Bac DJ, Feith GW. 2010. Liver cirrhosis due to hepatitis E in a kidney transplant patient. Ned Tijdschr Geneeskd 154:A1790.
40. Worm HC, van der Poel WH, Brandstatter G. 2002. Hepatitis E: An overview. Microbes Infect 4:657-666.